Quality of Life in Patients with Surgically Removed Skin Tumors
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Gordon, R. Skin cancer: An overview of epidemiology and risk factors. Semin. Oncol. Nurs. 2013, 29, 160–169. [Google Scholar] [CrossRef] [PubMed]
- Philipp-Dormston, W.G.; Müller, K.; Novak, B.; Strömer, K.; Termeer, C.; Hammann, U.; Glutsch, J.W.; Krähn-Senftleben, G.; Lübbert, H.; Koller, M.; et al. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: Results from a large-scale observational study analysing effects of diagnoses and disease progression. JEADV 2018, 32, 1138–1146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dodds, A.; Chia, A.; Shumack, S. Actinic keratosis: Rationale and management. Dermatol. Ther. 2014, 4, 11–31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Avilés Izquierdo, J.A.; Molina López, I.; Sobrini Morillo, P.; Márquez Rodas, I.; Mercader Cidoncha, E. Utility of PET/CT in patients with stage I–III melanoma. Clin. Transl. Oncol. 2019. [Google Scholar] [CrossRef] [PubMed]
- Peisker, A.; Raschke, G.F.; Guentsch, A.; Roshanghias, K.; Eichmann, F.; Schultze-Mosgau, S. Longterm quality of life after oncologic surgery and microvascular free flap reconstruction in patients with oral squamous cell carcinoma. Med. Oral Patol. Oral Cir. Bucal 2016, 21, e420–e424. [Google Scholar] [CrossRef] [PubMed]
- Vogel, R.I.; Strayer, L.G.; Engelman, L.; Nelson, H.H.; Blaes, A.H.; Anderson, K.E.; Lazovich, D. Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: A cross-sectional study. Qual. Life Res. 2017, 26, 1761–1766. [Google Scholar] [CrossRef] [PubMed]
- Abedini, R.; Nasimi, M.; Noormohammad Pour, P.; Moghtadaie, A.; Tohidinik, H.R. Quality of life in patients with non-melanoma skin cancer: Implications for healthcare education services and supports. J. Cancer Educ. 2019, 34, 755–759. [Google Scholar] [CrossRef] [PubMed]
- Linos, E.; Katz, K.A.; Colditz, G.A. Skin Cancer-The Importance of Prevention. JAMA Intern. Med. 2016, 176, 1435–1436. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fahradyan, A.; Howell, A.C.; Wolfswinkel, E.M.; Tsuha, M.; Sheth, P.; Wong, A.K. Updates on the Management of Non-Melanoma Skin Cancer (NMSC). Healthcare 2017, 5, 82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gaulin, C.; Sebaratnam, D.F.; Fernández-Peñas, P. Quality of life in non-melanoma skin cancer. Australas. J. Dermatol. 2015, 56, 70–76. [Google Scholar] [CrossRef] [PubMed]
- Fessa, C.K.; Man Ying Tsang, V.; Fenández-Peñas, P. Relationship between visibility of skin condition and quality of life. Australas. J. Dermatol. 2011, 52, 11. [Google Scholar]
- Essner, R. Surgical treatment of malignant melanoma. Surg. Clin. N. Am. 2003, 83, 109–156. [Google Scholar] [CrossRef]
- Tiglis, M.; Neagu, T.P.; Elfara, M.; Diaconu, C.C.; Bratu, O.G.; Vacaroiu, I.A.; Grintescu, I.M. Nefopam and its role in modulating acute and chronic pain. Rev. Chim. (Bucharest) 2018, 69, 2877–2880. [Google Scholar] [CrossRef]
- Diaconu, C.C.; Dragoi, C.M.; Bratu, O.G.; Neagu, T.P.; Stoian, P.; Cobelschi, P.C.; Nicolae, A.C.; Iancu, M.A.; Hainarosie, R.; Ana Maria Alexandra Stanescu, A.M.A.; et al. New approaches and perspectives for the pharmacological treatment of arterial hypertension. Farmacia 2018, 66, 408–415. [Google Scholar] [CrossRef]
- Balcangiu-Stroescu, A.E.; Tanasescu, M.D.; Diaconescu, A.; Raducu, L.; Balan, D.G.; Mihai, A.; Tanase, M.; Stanescu, I.I.; Ionescu, D. Diabetic nephropathy: A concise assessment of the causes, risk factors and implications in diabetic patients. Rev. Chim. (Bucharest) 2018, 69, 3118–3121. [Google Scholar] [CrossRef]
- Raducu, L.; Cozma, C.N.; BalcangiuStroescu, A.E.; Panduru, M.; Avino, A.; Tanasescu, M.D.; Badita, D.G.; Jecan, C.R. A rare case of a lower lip merkel cell carcinoma diagnosis and treatment. Rev. Chim. (Bucharest) 2018, 69, 354–357. [Google Scholar] [CrossRef]
- Raducu, L.; Balcangiu-Stroescu, A.E.; Stanescu, I.I.; Tanasescu, M.D.; Cozma, C.N.; Jecan, C.R.; Badita, D.G. Use of polyhexanidine in treating chronic wounds. Rev. Chim. (Bucharest) 2017, 68, 2112–2113. [Google Scholar]
- Rhee, J.S.; Matthews, B.A.; Neuburg, M.; Smith, T.L.; Burzynski, M.; Nattinger, A.B. Skin cancer and quality of life: Assessment with the dermatology life quality index. Dermatol. Surg. 2004, 30, 525–529. [Google Scholar] [CrossRef] [PubMed]
- Chernyshov, P.V.; Lallas, A.; Tomas-Aragones, L.; Arenbergerova, M.; Samimi, M.; Manolache, L.; Svensson, A.; Marron, S.E.; Sampogna, F.; Spillekom-vanKoulil, S.; et al. Quality of life measurement in skin cancer patients: Literature review and position paper of the european academy of dermatology and venereology task forces on quality of life and patient oriented outcomes, melanoma and non-melanoma skin cancer. J. Eur. Acad. Dermatol. Venereol. 2019, 33, 816–827. [Google Scholar] [CrossRef] [PubMed]
- Newton-Bishop, J.A.; Nolan, C.; Turner, F.; McCabe, M.; Boxer, C.; Thomas, J.M.; Coombes, G.; A’Hern, R.P.; Barrett, J.H. A quality-of-life study in high-risk (thickness ≥ 2 mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins. J. Investig. Dermatol. Symp. Proc. 2004, 9, 152–159. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Squamous Cell Carcinoma (SCC) Group (n = 38) | Malignant Melanoma (MM) Group (n = 20) | Basal Cell Carcinoma (BCC) Group (n = 168) | Actinic Keratosis (AK) Group (n = 21) | |
---|---|---|---|---|
Age (mean ± SD) | 74.47 ± 13.24 | 56.50 ± 18.53 | 68.67 ± 11.02 | 67.90 ± 16.20 |
Gender | ||||
Male | 26 (68%) | 12 (60%) | 91 (54%) | 13 (62%) |
Female | 12 (32%) | 8 (40%) | 77 (46%) | 8 (38%) |
Residence | ||||
Urban area | 21 (55%) | 18 (90%) | 105 (62%) | 17 (81%) |
Rural area | 17 (45%) | 2 (10%) | 63 (38%) | 4 (19%) |
SCC Group (n = 38) | MM Group (n = 20) | BCC Group (n = 168) | AK Group (n = 21) | |
---|---|---|---|---|
Maximum tumor diameter (median and range) | 2.25 (0.7–4.5) cm | 2.25 (0.6–9.5) cm | 1.45 (0.3–6) cm | 1.8 (0.3–3.8) cm |
Sun exposure | ||||
frequent | 33 (87%) | 10 (50%) | 109 (65%) | 17 (81%) |
less frequent | 5 (13%) | 10 (50%) | 59 (35%) | 4 (19%) |
Skin type | ||||
1 | 2 (5%) | 0 (0%) | 3 (2%) | 1 (5%) |
2 | 15 (40%) | 13 (65%) | 98 (58%) | 13 (62%) |
3 | 17 (45%) | 6 (30%) | 66 (39%) | 6 (28%) |
4 | 4 (10%) | 1 (5%) | 1 (1%) | 1 (5%) |
SCC Group (n = 38) | MM Group (n = 20) | BCC Group (n = 168) | AK Group (n = 21) | |
---|---|---|---|---|
Mobility | ||||
Hospital admission | 1.26 ± 0.6 | 1.60 ± 0.38 | 1.14 ± 0.35 | 1.10 ± 0.34 |
After one month | 1.16 ± 0.37 | 1.75 ± 0.58 | 1.10 ± 0.3 | 1.08 ± 0.27 |
After one year | 1 ± 0.00 | 1.35 ± 0.58 | 1 ± 0.00 | 1 ± 0.00 |
Selfcare | ||||
Hospital admission | 2.45 ± 0.5 | 2 ± 0.91 | 2.10 ± 0.62 | 2.10 ± 0.39 |
After one month | 1.97 ± 0.54 | 2.05 ± 0.6 | 1.43 ± 0.5 | 1.39 ± 0.5 |
After one year | 1.05 ± 0.22 | 1.40 ± 0.59 | 1.05 ± 0.21 | 1 ± 0.00 |
Normal activities | ||||
Hospital admission | 2.68 ± 0.62 | 2.05 ± 0.99 | 2.38 ± 0.66 | 2.29 ± 0.46 |
After one month | 2.11 ± 0.55 | 2.20 ± 0.61 | 1.67 ± 0.73 | 1.46 ± 0.52 |
After one year | 1.05 ± 0.22 | 1.70 ± 0.65 | 1 ± 0.00 | 1.01 ± 0.07 |
Pain/discomfort | ||||
Hospital admission | 2.58 ± 0.55 | 2.05 ± 0.94 | 2.43 ± 0.5 | 2.26 ± 0.47 |
After one month | 1.87 ± 0.34 | 2 ± 0.45 | 1.57 ± 0.5 | 1.41 ± 0.49 |
After one year | 1 ± 0.00 | 1.55 ± 0.60 | 1 ± 0.00 | 1 ± 0.00 |
Despair | ||||
Hospital admission | 2.89 ± 0.69 | 2.10 ± 0.71 | 4 ± 0.77 | 4.23 ± 0.63 |
After one month | 3.95 ± 0.92 | 4.70 ± 0.57 | 2.14 ± 0.57 | 2.10 ± 0.44 |
After one year | 1.58 ± 0.5 | 2.75 ± 0.44 | 1 ± 0.00 | 1 ± 0.00 |
General health state | ||||
Hospital admission | 48.95 ± 9.25 | 78 ± 12.8 | 31.9 ± 7.49 | 29.20 ± 6.64 |
After one month | 30.13 ± 10.55 | 21.5 ± 8.75 | 57.14 ± 9.56 | 59.35 ± 7.02 |
After one year | 83.16 ± 7.74 | 59 ± 9.67 | 91.9 ± 7.49 | 94.46 ± 6.63 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Răducu, L.; Avino, A.; Purnichescu Purtan, R.; Balcangiu-Stroescu, A.-E.; Bălan, D.G.; Timofte, D.; Ionescu, D.; Jecan, C.-R. Quality of Life in Patients with Surgically Removed Skin Tumors. Medicina 2020, 56, 66. https://doi.org/10.3390/medicina56020066
Răducu L, Avino A, Purnichescu Purtan R, Balcangiu-Stroescu A-E, Bălan DG, Timofte D, Ionescu D, Jecan C-R. Quality of Life in Patients with Surgically Removed Skin Tumors. Medicina. 2020; 56(2):66. https://doi.org/10.3390/medicina56020066
Chicago/Turabian StyleRăducu, Laura, Adelaida Avino, Raluca Purnichescu Purtan, Andra-Elena Balcangiu-Stroescu, Daniela Gabriela Bălan, Delia Timofte, Dorin Ionescu, and Cristian-Radu Jecan. 2020. "Quality of Life in Patients with Surgically Removed Skin Tumors" Medicina 56, no. 2: 66. https://doi.org/10.3390/medicina56020066
APA StyleRăducu, L., Avino, A., Purnichescu Purtan, R., Balcangiu-Stroescu, A. -E., Bălan, D. G., Timofte, D., Ionescu, D., & Jecan, C. -R. (2020). Quality of Life in Patients with Surgically Removed Skin Tumors. Medicina, 56(2), 66. https://doi.org/10.3390/medicina56020066